Carvedilol decreases elevated oxidative stress in human failing myocardium.
Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, Yamamoto M, Miyaji K, Saito H, Morita H, Emori T, Matsubara H, Toyokuni S, Ohe T.
Nakamura K, et al. Among authors: miyaji k.
Circulation. 2002 Jun 18;105(24):2867-71. doi: 10.1161/01.cir.0000018605.14470.dd.
Circulation. 2002.
PMID: 12070115
Clinical Trial.